Deerfield Management’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
Other funds holding PYXS
BI
RCM
RI
PA
LCM
HA
CAM
Deerfield Management's PYXS Position: Q1 2022 in Review
Deerfield Management sold out of Pyxis Oncology (PYXS) in Q1 2022, closing a stake of 311,754 shares — an estimated $3.42M sold.
Deerfield Management first reported a position in PYXS in Q4 2021 and held it in 1 quarter. The position peaked at $3.42M in Q4 2021. 45 funds tracked by Wall St. Rank hold PYXS as of Q1 2022.
- Deerfield Management reported no remaining Pyxis Oncology position as of Q1 2022 after selling out during the quarter.
- Deerfield Management sold 311,754 Pyxis Oncology shares in Q1 2022, an estimated $3.42M.
- Deerfield Management first reported a position in Pyxis Oncology in Q4 2021 and held it in 1 quarter.
- Deerfield Management's Pyxis Oncology position peaked at $3.42M in Q4 2021.
- 45 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2022.
Based on Deerfield Management's 13F filing for Q1 2022, filed 16 May 2022.